Korea has approved new combinations using Johnson & Johnson (J&J) Innovative Medicine’s Rybrevant (amivantamab), expanding ...

HLB has secured FDA for Lyrfigtu (lirafugratinib), an fibroblast growth factor receptor 2 (FGFR2)-targeted cancer drug for ...

Onconic Therapeutics’ Chinese partner has dosed the first patient in a phase 3 trial of an injectable formulation of ...

For decades, radiologists have injected gadolinium-based contrast agents directly into patients’ joints for magnetic ...

Calls are growing for an overhaul of Korea’s disability assessment criteria for dwarfism, which critics say have direct ...

A hospital has formally apologized to the family of a nurse who had reported workplace bullying before her death and agreed ...

Nineteen recipients of government public health scholarships have failed to complete their mandatory service without ...

Sepsis, a condition in which an abnormal, excessive immune response to infection damages major organs, is a medical emergency ...

Compass Therapeutics said Monday that U.S. regulators have recommended it run a trial showing a survival benefit before ...

Daewoong Pharmaceutical has launched its gastroesophageal reflux disease (GERD) treatment Fexuclue (fexuprazan) in Indonesia, ...

As the government moves to formally introduce medication abortion, a National Assembly research body has called for drug ...

Korea’s spending on healthcare services and medical goods provided directly to individual patients surpassed 200 trillion won ...